EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluorescent NHC Gold(I) Complexes as Tools for Target Identification and Metallomic Studies in Cancer Cells

Ester Giorgi, Matteo Boldrini, Francesca Binacchi iD, Damiano Cirri, Michele Mannelli iD, Tania Gamberi iD, Massimo Guelfi iD, Matteo Becatti, Lara Massai iD, Chiara Gabbiani iD, Alessandro Pratesi iD, Luigi Messori iD

Inorganic Chemistry · 17.08.2026 · 65 (32) · 18593-18607

DOI: 10.1021/acs.inorgchem.6c01796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 03.08.2026. Verfasst von Ester Giorgi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Industrial Chemistry, University of Pisa, Via G. Moruzzi 13, 56124Pisa, Italy. Hauptthemen laut MEDLINE: Fluorescent Dyes, Antineoplastic Agents, Gold, Heterocyclic Compounds. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, NextGenerationEU, Ministero dell?Istruzione, dell?Universit? e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, gold(I) complexes have attracted increasing interest as an alternative to conventional metallo-chemotherapeutic agents. Their mode of action differs significantly from that of traditional platinum-based drugs. However, the identification of their intracellular targets and the elucidation of their mechanisms of action remain major challenges, largely due to the lack of suitable molecular tools for tracking these compounds in biological systems. To address these issues, three novel gold(I) complexes bearing two different fluorescent labels were synthesized and characterized. These complexes include an N-heterocyclic monocarbene gold(I) complex 3 and the corresponding biscarbene 4, both of which are functionalized with an anthracenyl moiety, as well as an NHC gold(I) monocarbene complex bearing a BODIPY label 5. The specific aim of this study was to generate trackable metallodrug models for mechanistic and metallomics-oriented research. These compounds were characterized using 1H and 13C NMR spectroscopy and elemental analysis. The crystallographic structure of the anthracenyl gold monocarbene was also determined. Interaction studies with human serum albumin (HSA) using UV–vis absorption spectroscopy and ESI-MS provided clear evidence of metallodrug–protein interactions. The uptake of the complexes in A2780 ovarian cancer cells was measured using fluorescence-activated cell sorting (FACS) cytofluorimetry, which indicated strong cellular uptake for the anthracenyl-labeled compounds 3 and 4. A cell fractionation approach was used for the quantitative analysis of subcellular drug disposition. These approaches collectively enabled a direct visualization of the intracellular fate of the gold complexes, providing a framework for correlating cellular distribution with biological activity. Finally, the gold complexes bearing the anthracenyl probe were evaluated for their cytotoxic activity in cisplatin-sensitive and -resistant A2780 cancer cells; the BODIPY complex could not be evaluated due to its insolubility. Overall, this study provides solid evidence that gold complexes bearing the anthracenyl probe retain significant cytotoxic properties and enable monitoring the uptake and fate of these gold species inside cancer cells, thus providing a proof-of-concept that fluorescently labeled gold complexes can serve as powerful tools for mechanistic investigations, including metallomics and proteomics-oriented studies aimed at identifying molecular targets and affected pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesAntineoplastic AgentsGoldHeterocyclic CompoundsMethaneOrganogold CompoundsHumansCell Line, TumorMolecular StructureFluorescent Chemosensor CompoundsSerum Albumin, HumanCell ProliferationModels, MolecularDrug Screening Assays, Antitumor

Substanzen

Fluorescent DyesAntineoplastic AgentsGoldcarbeneHeterocyclic CompoundsMethaneFluorescent Chemosensor CompoundsSerum Albumin, HumanOrganogold Compounds

Autor:innen und Institutionen

  • Department of Chemistry and Industrial Chemistry, University of Pisa, Via G. Moruzzi 13, 56124Pisa, Italy.
  • Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale G.B. Morgagni 50, 50134Firenze, Italy.
  • Department of Chemistry "U. Schiff", University of Florence, Via della Lastruccia 3-13, 50019Sesto Fiorentino, Italy.

ORCID-Profile: Francesca Binacchi, Michele Mannelli, Tania Gamberi, Massimo Guelfi, Lara Massai, Chiara Gabbiani, Alessandro Pratesi, Luigi Messori

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • NextGenerationEU
  • Ministero dell?Istruzione, dell?Universit? e della Ricerca

Zitieren

APA

Giorgi, E., Boldrini, M., Binacchi, F., Cirri, D., Mannelli, M., Gamberi, T., Guelfi, M., Becatti, M., Massai, L., Gabbiani, C., Pratesi, A., & Messori, L. (2026). Fluorescent NHC Gold(I) Complexes as Tools for Target Identification and Metallomic Studies in Cancer Cells. Inorganic Chemistry, 65(32), 18593-18607. https://doi.org/10.1021/acs.inorgchem.6c01796

Vancouver

Giorgi E, Boldrini M, Binacchi F, Cirri D, Mannelli M, Gamberi T, et al. Fluorescent NHC Gold(I) Complexes as Tools for Target Identification and Metallomic Studies in Cancer Cells. Inorganic Chemistry. 2026;65(32):18593-18607. doi:10.1021/acs.inorgchem.6c01796

BibTeX
@article{Giorgi2026,
  author = {Giorgi, Ester and Boldrini, Matteo and Binacchi, Francesca and Cirri, Damiano and Mannelli, Michele and Gamberi, Tania and Guelfi, Massimo and Becatti, Matteo and Massai, Lara and Gabbiani, Chiara and Pratesi, Alessandro and Messori, Luigi},
  title = {Fluorescent NHC Gold(I) Complexes as Tools for Target Identification and Metallomic Studies in Cancer Cells},
  journal = {Inorganic Chemistry},
  year = {2026},
  volume = {65},
  number = {32},
  pages = {18593--18607},
  doi = {10.1021/acs.inorgchem.6c01796}
}
Kostenlos starten →